Yahoo
NasdaqCM - Delayed Quote USD

enGene Therapeutics Inc. (ENGN)

1.4500 -0.0800 (-5.23%)
At close: November 2 at 4:00:02 PM EST
Trade ENGN on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
10/31/2025
10/31/2024
10/31/2023
10/31/2022
Total Revenue
0
0
0
0
0
Operating Expense
136,648
123,165
62,297
26,060
19,427
Operating Income
-136,648
-123,165
-62,297
-26,060
-19,427
Net Non Operating Interest Income Expense
6,709
6,432
7,615
-3,836
-1,294
Other Income Expense
-918
-569
-479
-70,004
-3,719
Pretax Income
-130,857
-117,302
-55,161
-99,900
-24,440
Tax Provision
-497
0
-19
17
22
Net Income Common Stockholders
-130,360
-117,302
-55,142
-104,739
-29,024
Diluted NI Available to Com Stockholders
-130,360
-117,302
-55,142
-104,739
-29,024
Basic EPS
-2.07
-2.29
-1.46
-4.52
-1.25
Diluted EPS
-2.07
-2.29
-1.46
-4.52
-1.25
Basic Average Shares
64,519.6810
51,119.4790
37,782.3460
23,197.9760
23,197.9760
Diluted Average Shares
64,519.6810
51,119.4790
37,782.3460
23,197.9760
23,197.9760
Total Operating Income as Reported
-136,648
-123,165
-62,297
-26,060
-19,427
Total Expenses
136,648
123,165
62,297
26,060
19,427
Net Income from Continuing & Discontinued Operation
-130,360
-117,302
-55,142
-99,917
-24,462
Normalized Income
-129,873.8534
-117,302
-54,776.1098
-91,719.2000
-22,206.2397
Interest Income
9,779
9,426
10,413
1,117
129
Interest Expense
3,070
2,994
2,798
4,953
1,423
Net Interest Income
6,709
6,432
7,615
-3,836
-1,294
EBIT
-127,787
-114,308
-52,363
-94,947
-23,017
EBITDA
-127,069
-113,799
-52,040
-94,772
-22,779
Reconciled Depreciation
718
509
323
175
238
Net Income from Continuing Operation Net Minority Interest
-130,360
-117,302
-55,142
-99,917
-24,462
Total Unusual Items Excluding Goodwill
-488
0
-366
-13,663
-3,057
Total Unusual Items
-488
0
-366
-13,663
-3,057
Normalized EBITDA
-126,581
-113,799
-51,674
-81,109
-19,722
Tax Rate for Calcs
0
0
0
0.0004
0.0003
Tax Effect of Unusual Items
-1.8534
0
-0.1098
-5,465.2000
-801.2397
10/31/2022 - 2/1/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: